Pharmindex Poland

What Pharmindex Poland does

PHARMINDEX Poland Sp. z o.o. is a privately held Polish pharmaceutical information company headquartered in Warsaw, operating for over 20 years as the self-described most popular drug database in Poland. Its core product, Baza Leków Pharmindex, is a curated database of medicinal products available in Polish regular sale, with drug descriptions verified against current CHPL/SPC documents and continuously updated through collaboration with pharmaceutical company medical departments. The platform is extended by modular add-ons including Asystent MD (therapeutic decision support), PHARMINDEX PLUS and Pharmindex Szpital (hospital drug interaction comparison), Alerty Bezpieczeństwa (color-coded graphical safety profiles across ten parameters including pregnancy, lactation, hepatic and renal function, driving, alcohol, brain effects, diagnostic test interference, age reimbursement, and FORTA geriatric classification), Interakcje.pl and bazainterakcji.pl (drug interaction detection), an e-recepta browser plugin, and reference tools such as lekiICD10.pl, Zamienniki (substitutes), Trener Recept (prescription training), Farmaceuta, inhalatory.edu.pl, Więcej niż LEK, and Polish-Ukrainian medical dictionaries.

The business serves physicians across all medical specialties, pharmacists, nurses, midwives, medical students, and hospital institutions in Poland through a horizontal segmentation approach. Revenue is generated primarily via recurring subscriptions to database access, mobile applications, hospital modules, and the bundled Pharmindex COMPLETE offering, with a smaller professional-services tail from educational resources. Distribution combines self-serve digital access through pharmindex.pl and mobile apps, a direct hospital sales motion for PHARMINDEX PLUS, IT-representative channel sales, and deep OEM-style integrations with the dominant Polish clinical IT platforms KS-Somed, KS-PPS, and SERUM. Pricing is not publicly disclosed and orders are processed through IT representatives or via the [email protected] contact channel. The company is independently owned, with no identified parent, subsidiaries, external investors, or public funding rounds.

Name

Pharmindex Poland

Legal name

PHARMINDEX Poland Sp. z o.o.

Website

https://pharmindex.pl

Company type

Private

Operating status

Operating

Short description

PHARMINDEX Poland Sp. z o.o. operates Poland's most popular drug database, serving physicians, pharmacists, nurses, midwives, students, and hospitals with subscription access to CHPL-verified drug information, interaction checking, and clinical decision support modules.

Ownership category

akta.pro rank

Product category

Pharmaceutical Information Software

NAICS

Other Scientific and Technical Consulting Services (541690)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Pharmacy Information Systems (PIS) & Dispensing Workflow (HLACAKAC)

akta.pro secondary industries

Pharmacovigilance & Drug Safety Software (HLAGAJAK), Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH)

Keywords

• Pharmaceutical database software
• Clinical decision support
• Drug interaction checking
• E-prescription tools
• Medical drug information

Headquarters

HQ city

Warszawa

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Database Access and Software Subscriptions: Pharmindex generates revenue through professional database access and computer programs for healthcare professionals, including Asystent MD and PHARMINDEX PLUS tools offered to medical facilities.
2. Mobile Applications: Pharmindex mobile application offered to healthcare professionals for drug information access on mobile devices.
3. Hospital Solutions: Pharmindex szpital (hospital version) provides specialized tools for hospital facilities with drug interaction comparison capabilities.
4. Educational Resources: Educational materials, podcasts, prescription training tools, and Polish-Ukrainian dictionaries for healthcare professionals.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Pharmindex Poland provides a comprehensive drug database (Baza Leków Pharmindex) verified against current SPCs (ChPL), along with clinical decision support tools for Polish healthcare professionals. The platform offers drug interaction checking, graphical safety alerts across 10 risk parameters, therapeutic decision assistance (Asystent MD), and hospital medication management (PHARMINDEX PLUS). Their offerings include mobile applications, e-prescription plugins, ICD-10 code search, and educational tools used by physicians, pharmacists, nurses, midwives, and medical students.

Product overview

Pharmindex Poland Sp. z o.o. offers a comprehensive pharmaceutical knowledge ecosystem built around its core Baza Leków Pharmindex (Pharmindex Drug Database) — a high-quality database of medicinal products verified against current SPCs (ChPL) and safety notifications. The portfolio follows a platform-plus-modules architecture where the core database serves as the foundation for specialized add-on modules including Asystent MD (therapeutic decision support), PHARMINDEX PLUS (hospital drug interaction comparison), Safety Alerts (graphical safety profiles with color-coded risk indicators), Interakcje.pl/bazainterakcji.pl (drug interaction checking), and e-recepta (e-prescription plugin). The offering extends to Pharmindex mobile (mobile application), Pharmindex Szpital (hospital-specific version), Pharmindex COMPLETE (comprehensive package), and supplementary tools such as Trener Recept (prescription training), lekiICD10.pl (ICD-10 codes), inhalatory.edu.pl (inhaler instructions), Zamienniki (drug substitutes), Więcej niż LEK (medical education portal), and language support tools. With over 20 years of experience, Pharmindex is the most popular drug database in Poland, serving physicians across all specialties, pharmacists, nurses, midwives, and medical students.

Differentiator

Problem solved

Functional benefit

Brands

• Asystent MD: Decision support system for therapeutic decisions
• PHARMINDEX PLUS
• Pharmindex mobile
• Pharmindex COMPLETE
• interakcje.pl
• bazainterakcji.pl
• Alerty Bezpieczeństwa
• Trener Recept
• inhalatory.edu.pl
• lekiICD10.pl
• Farmaceuta

Products and services

• Baza Leków Pharmindex (Pharmindex Drug Database) Comprehensive database of medicinal products available in Poland, with drug descriptions verified against current SPCs (ChPL), safety notifications, and continuous monitoring by pharmaceutical company medical departments. Provides fast access to prescription-relevant information for healthcare professionals.
• Pharmindex Mobile Professional drug information mobile application providing on-the-go access to the Pharmindex drug database for doctors, pharmacists, nurses, midwives, and medical students.
• PHARMINDEX PLUS / Pharmindex Szpital Hospital module enabling comparison of drug interactions between two or more medications, designed for hospital facility medication management and ward pharmacy operations.
• Alerty Bezpieczeństwa (Safety Alerts) Graphical drug safety profile system with color-coded risk icons covering pregnancy, lactation, liver, kidneys, driving ability, alcohol interactions, brain effects, diagnostic test interference, age-based reimbursement, and geriatrics (FORTA classification). Includes data on 2115 drugs affecting diagnostic tests, 2000+ drugs with age reimbursement restrictions, and 6500+ drugs with geriatric safety information.
• Interakcje.pl Drug interaction checking service providing clinically significant interactions for healthcare professionals, based on Scandinavian quality standards adapted for Polish physicians.
• bazainterakcji.pl Drug interaction database tool offering interaction detection sets for all medications, developed by physicians for physicians.
• Trener Recept (Prescription Trainer) Educational tool providing information about prescription rules and regulations, including e-prescription guidelines under the Polish DNUR (Duża Nowelizacja Ustawy Refundacyjnej).
• Pharmindex COMPLETE Comprehensive package offering full access to all Pharmindex services and modules bundled together.
• Farmaceuta (Pharmacist Module) Module focused on pharmacist-specific needs and workflows, supporting drug dispensing and patient counseling activities.
• Komunikaty Bezpieczeństwa (Safety Communications) Safety communication alerts keeping healthcare professionals informed about drug safety updates, regulatory changes, and verified safety communications from pharmaceutical companies.
• Zamienniki (Drug Substitutes) Drug substitute finder enabling identification of alternative medications available in the Polish market.
• inhalatory.edu.pl Free professional tool containing instructions for using inhalers in video format, usage guidelines, and patient leaflets with sharing capabilities.

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Four partnerships are on record, tiered core.

• Healthcare IT System ProviderscoreTechnology or IntegrationPharmindex collaborates with leading Polish healthcare IT system providers to integrate its drug database into clinical workflow systems including KS-Somed, KS-PPS, and SERUM platforms.
• Private Medical Services ProviderscoreTechnology or IntegrationPharmindex partners with major private medical services providers in Poland to deliver drug information and decision support tools.
• Naczelną Izbę Lekarską (Supreme Medical Chamber)coreStrategic or Co-development PartnerCollaboration with the Supreme Medical Chamber of Poland to prepare Polish-Ukrainian medical dictionaries and medical interview forms for Ukrainian patients, supporting healthcare professionals working with Ukrainian refugees.
• Pharmaceutical Companies (Medical Departments)coreStrategic or Co-development PartnerPharmindex works with pharmaceutical company medical departments to monitor drug descriptions and provide verified safety communications, ensuring database accuracy.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• DrugBank: Commercial drug knowledge platform providing structured drug data, interactions, and APIs to developers, researchers, and clinicians. Comparable to Pharmindex as a drug database and interaction product, though distributed via APIs/SDKs rather than a regional clinical portal.
• Epocrates: Mobile-first drug reference and interaction checker widely used by physicians in the US. Closely comparable to Pharmindex mobile and Interakcje.pl in product form factor and prescriber-centric workflow, with similar freemium/upsell monetization.
• Rote Liste: Germany's standard drug reference compendium used by physicians and pharmacists, with deep integration into German clinical workflows. Directly comparable to Pharmindex as a regionally dominant, clinically validated drug reference with hospital and prescribing-channel distribution.
• Vidal Group: French-headquartered drug information database provider serving healthcare professionals with monographs, interactions, and decision support. Closest geographic analogue to Pharmindex as a national drug database specialist with similar subscription-driven B2B/enterprise monetization.

Broad incumbents

• Wolters Kluwer Lexicomp: International clinical drug reference and decision support platform covering interactions, IV compatibility, and patient education used in hospitals worldwide. Comparable to Pharmindex's PHARMINDEX PLUS and Interakcje.pl offerings but at global scale and embedded in EHR systems.
• FDB (First Databank): Provider of drug knowledge bases and medication decision support integrated into EHR and pharmacy systems worldwide. Closely comparable to Pharmindex's drug database and integration model with KS-Somed/KS-PPS/SERUM, but at international scale.
• UpToDate (Wolters Kluwer): Global clinical decision support resource used by physicians across specialties, including drug and dosing guidance. Adjacent competitor to Pharmindex's Asystent MD for therapeutic decision support, though much broader in scope and evidence-based content.
• Medi-Span (Wolters Kluwer): Drug database and clinical screening solutions embedded into hospital pharmacy and EHR workflows globally. Comparable to Pharmindex's hospital drug-interaction modules but distributed through enterprise integrations rather than regional subscriptions.
• IBM Micromedex: Enterprise drug information and clinical decision support solution sold to hospitals and health systems globally. Overlaps with Pharmindex's hospital and safety-alert modules but is part of a much broader portfolio including evidence-based clinical content.

Emerging players

• Elsevier ClinicalKey: Clinical search and decision support platform combining drug content with broader medical evidence, increasingly used by hospital systems. Represents the convergence of clinical decision support and drug reference that Pharmindex's Asystent MD and hospital modules compete against.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC6tG_QN0yrERHeNVcR9J94w/videos
• Facebookfacebook.com/pharmindexPL

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmindex Poland